GENE ONLINE|News &
Opinion
Blog

2025-12-01|

Researchers Explore Ionic Liquids to Enhance Stability of Perovskite Solar Cells

by GOAI
Share To

Researchers have identified a potential solution to improve the operational stability of perovskite solar cells (PSCs), a technology known for its high power conversion efficiency and cost-effective production. A recent study highlights the use of ionic liquids as an additive to enhance the stability of halide perovskite materials, which are prone to degradation over time. This instability has been a significant obstacle in advancing PSCs toward widespread commercial application.

The instability issue arises from the inherent properties of halide perovskites, which degrade under prolonged exposure to environmental factors such as moisture, heat, and light. The study demonstrates that incorporating ionic liquids into the material structure can mitigate these effects by stabilizing the perovskite layer and reducing degradation rates. Researchers suggest this approach could address one of the primary challenges facing PSCs, potentially paving the way for more durable and reliable solar energy solutions. Further investigation is ongoing to evaluate long-term performance and scalability of this method.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top